New Zealand court strips parental custody over refusal to allow blood transfer from vaxed donors
Parents of a New Zealand baby lost medical guardianship of 'Baby W' for refusing to allow crucial blood transfusions unless they came from a donor who had not received an mRNA Covid vaccine. (Source: the Mail online | Health)
Source: the Mail online | Health - December 7, 2022 Category: Consumer Health News Source Type: news

New Zealand court rules against anti-vax parents of ill baby
A New Zealand court has temporarily taken away medical custody of a baby from his parents after they refused blood transfusions for him unless the blood comes from donors who are unvaccinated against COVID-19 (Source: ABC News: Health)
Source: ABC News: Health - December 7, 2022 Category: Consumer Health News Tags: Health Source Type: news

In a First, Doctors Treat a Fatal Genetic Disease Before Birth
A toddler is thriving after doctors in the U.S. and Canada used a novel technique to treat her before she was born for a rare genetic disease that caused the deaths of two of her sisters. Ayla Bashir, a 16-month-old from Ottawa, Ontario, is the first child treated as fetus for Pompe disease, an inherited and often fatal disorder in which the body fails to make some or all of a crucial protein. Today, she’s an active, happy girl who has met her developmental milestones, according to her father, Zahid Bashir and mother, Sobia Qureshi. “She’s just a regular little 1½-year-old who keeps us on our toes,...
Source: TIME: Health - November 10, 2022 Category: Consumer Health News Authors: JONEL ALECCIA/AP Tags: Uncategorized Disease healthscienceclimate wire Source Type: news

Groundbreaking clinical trial gives lab-grown red blood cells to people for the first time
A world-first clinical trial funded and supported by NIHR has started giving lab-grown red blood cells to people. If proved safe and effective, the technology could revolutionise treatments for people with rare blood types, blood disorders such as sickle cell, or people who aren ' t able to have normal blood transfusions. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 8, 2022 Category: Consumer Health News Source Type: news

Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Advocacy in Hemophilia: Building the Future by Design
Advances in the treatment and care of hemophilia have accelerated in recent years. And, according to Jack Uldrich, global futurist and author, the field could be on the precipice of even more disruptive changes, coming at an accelerated pace.Uldrich explains that multiple innovations could potentially advance the field. These new frontiers include gene therapy and many other novel treatment approaches, such as mobile and decentralized blood-testing technology, artificial intelligence, nanomaterials for the delivery of novel treatments, advancements in battery technology (enabling drone-blood-delivery services), synthetic b...
Source: EyeForPharma - November 3, 2022 Category: Pharmaceuticals Authors: Clare Jackson Source Type: news

Doctors seeing resistance to blood transfusions over unfounded COVID vaccine concerns
Alberta physicians are raising the alarm about a dangerous trend — fuelled by misinformation — that could cost lives. Some patients are refusing to consent to a blood transfusion if it came from a donor who received the COVID-19 vaccine. (Source: CBC | Health)
Source: CBC | Health - October 13, 2022 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news

Infected blood transfusions killed 1,820 in UK, study estimates
Study estimates 27,000 people were infected with hepatitis C in UK after surgery in 1970s and 1980s. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 17, 2022 Category: Consumer Health News Source Type: news

Rwanda: Rwanda to Be Part of Global Drive to Raise 50,000 Blood Units in a Day
[New Times] 300 units of blood are needed per day to sustain hospitals in the country, according to Dr Thomas Muyombo, the head of the National Centre for Blood Transfusion at Rwanda Biomedical Centre. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 29, 2022 Category: African Health Source Type: news

Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX ® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma
LOS ANGELES, August 27, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the final results from the randomized Phase 2 GRIFFIN study evaluating the investigational use of DARZALEX® (daratumumab) in combination with lenalidomide (Revlimid®), bortezomib (VELCADE®) and dexamethasone (DARZALEX®-RVd), followed by maintenance therapy with DARZALEX®-lenalidomide (R), compared to RVd followed by maintenance therapy with R alone, in patients with newly diagnosed, transplant-eligible multiple myeloma. Data were presented in the plenary session at the 19th International Myeloma Society (IMS)...
Source: Johnson and Johnson - August 28, 2022 Category: Pharmaceuticals Source Type: news

Africa: Uganda Wins Bid to Host Africa Blood Transfusion Conference
[Nile Post] Uganda has won the bid to host the next conference of the Africa Society for Blood Transfusion set for March,1 to 4, 2024. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 26, 2022 Category: African Health Source Type: news

Sufferers of rare genetic blood disease plead with NHS for 'life-changing' US gene therapy
In studies, the one-off transfusion of Zynteglo freed nine in ten patients who had thalassaemia from the twice-monthly blood transfusions they needed to survive. (Source: the Mail online | Health)
Source: the Mail online | Health - August 21, 2022 Category: Consumer Health News Source Type: news

Eritrea: Voluntary Blood Donation
[Shabait] Asmara, 12 August 2022- Voluntary blood donation with the aim to enrich the National Blood Transfusion Service was conducted in connection with 12 August, World Youth Day. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 15, 2022 Category: African Health Source Type: news

Newest Dana-Farber Brigham Cancer Center opens in Foxborough
The facility will offer medical oncology and hematology care, blood transfusions, clinical trials and pharmacy. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 11, 2022 Category: Health Management Authors: Cassie McGrath Source Type: news

Haemophilia can be cured through 'miracle' therapy
University College London researchers say a one-off gene therapy blood transfusion could stop people with haemophilia having to take weekly injections to manage the rare condition. (Source: the Mail online | Health)
Source: the Mail online | Health - July 21, 2022 Category: Consumer Health News Source Type: news